Search research articles
Contact Us
Filters
Showing results (681-690 of 913) with videos related to
Page
of 92
Sort By:
Journal of the American College of Cardiology
|
November 6, 2020
Influence of LDL-Cholesterol Lowering on Cardiovascular Outcomes in Patients With Diabetes Mellitus Undergoing Coronary Revascularization
Michael E Farkouh, Lucas C Godoy, Maria M Brooks, et al.
Journal of the American College of Cardiology
|
June 18, 2021
Triglycerides and Residual Atherosclerotic Risk
Sergio Raposeiras-Roubin, Xavier Rosselló, Belén Oliva, et al.
JACC. Cardiovascular Imaging
|
September 13, 2024
Coronary Microvascular Function in Asymptomatic Middle-Aged Individuals With Cardiometabolic Risk Factors
Ana Devesa, Valentin Fuster, Inés García-Lunar, et al.
JACC. Heart Failure
|
July 30, 2021
Mechanistic Insights of Empagliflozin in Nondiabetic Patients With HFrEF: From the EMPA-TROPISM Study
Juan Antonio Requena-Ibáñez, Carlos G Santos-Gallego, Anderly Rodriguez-Cordero, et al.
JACC. Cardiovascular Imaging
|
July 4, 2016
Clinical Utility of Combined FDG-PET/MR to Assess Myocardial Disease
Ronan Abgral, Marc R Dweck, Maria Giovanna Trivieri, et al.
JACC. Cardiovascular Imaging
|
May 13, 2023
Advances in Coronary Computed Tomographic Angiographic Imaging of Atherosclerosis for Risk Stratification and Preventive Care
Solomon Bienstock, Fay Lin, Ron Blankstein, et al.
JACC. Cardiovascular Imaging
|
November 1, 2020
Empagliflozin Ameliorates Diastolic Dysfunction and Left Ventricular Fibrosis/Stiffness in Nondiabetic Heart Failure: A Multimodality Study
Carlos G Santos-Gallego, Juan Antonio Requena-Ibanez, Rodolfo San Antonio, et al.
Cardiovascular Drugs and Therapy
|
January 25, 2019
Rationale and Design of the EMPA-TROPISM Trial (ATRU-4): Are the "Cardiac Benefits" of Empagliflozin Independent of its Hypoglycemic Activity?
Carlos G Santos-Gallego, Alvaro Garcia-Ropero, Donna Mancini, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 9, 2020
Characterization of Patients Who Return to Hospital Following Discharge from Hospitalization For COVID-19
Sulaiman Somani, Felix Richter, Valentin Fuster, et al.
European Heart Journal. Cardiovascular Imaging
|
August 2, 2013
Coronary artery calcification is inversely related to body morphology in patients with significant coronary artery disease: a three-dimensional intravascular ultrasound study
George D Dangas, Akiko Maehara, Solene M Evrard, et al.
Page
of 92
Search research articles
Search
Showing results (681-690 of 913) with videos related to
Sort By:
Page
of 92
Journal of the American College of Cardiology
|
November 6, 2020
Influence of LDL-Cholesterol Lowering on Cardiovascular Outcomes in Patients With Diabetes Mellitus Undergoing Coronary Revascularization
Michael E Farkouh, Lucas C Godoy, Maria M Brooks, et al.
Journal of the American College of Cardiology
|
June 18, 2021
Triglycerides and Residual Atherosclerotic Risk
Sergio Raposeiras-Roubin, Xavier Rosselló, Belén Oliva, et al.
JACC. Cardiovascular Imaging
|
September 13, 2024
Coronary Microvascular Function in Asymptomatic Middle-Aged Individuals With Cardiometabolic Risk Factors
Ana Devesa, Valentin Fuster, Inés García-Lunar, et al.
JACC. Heart Failure
|
July 30, 2021
Mechanistic Insights of Empagliflozin in Nondiabetic Patients With HFrEF: From the EMPA-TROPISM Study
Juan Antonio Requena-Ibáñez, Carlos G Santos-Gallego, Anderly Rodriguez-Cordero, et al.
JACC. Cardiovascular Imaging
|
July 4, 2016
Clinical Utility of Combined FDG-PET/MR to Assess Myocardial Disease
Ronan Abgral, Marc R Dweck, Maria Giovanna Trivieri, et al.
JACC. Cardiovascular Imaging
|
May 13, 2023
Advances in Coronary Computed Tomographic Angiographic Imaging of Atherosclerosis for Risk Stratification and Preventive Care
Solomon Bienstock, Fay Lin, Ron Blankstein, et al.
JACC. Cardiovascular Imaging
|
November 1, 2020
Empagliflozin Ameliorates Diastolic Dysfunction and Left Ventricular Fibrosis/Stiffness in Nondiabetic Heart Failure: A Multimodality Study
Carlos G Santos-Gallego, Juan Antonio Requena-Ibanez, Rodolfo San Antonio, et al.
Cardiovascular Drugs and Therapy
|
January 25, 2019
Rationale and Design of the EMPA-TROPISM Trial (ATRU-4): Are the "Cardiac Benefits" of Empagliflozin Independent of its Hypoglycemic Activity?
Carlos G Santos-Gallego, Alvaro Garcia-Ropero, Donna Mancini, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 9, 2020
Characterization of Patients Who Return to Hospital Following Discharge from Hospitalization For COVID-19
Sulaiman Somani, Felix Richter, Valentin Fuster, et al.
European Heart Journal. Cardiovascular Imaging
|
August 2, 2013
Coronary artery calcification is inversely related to body morphology in patients with significant coronary artery disease: a three-dimensional intravascular ultrasound study
George D Dangas, Akiko Maehara, Solene M Evrard, et al.
Page
of 92